WeightWatchers is making potatoes OK again as the storied weight management company leans into compounded GLP-1s, AI and B2B.
As GLP-1 drugs surge, here's how telehealth companies and brick-and-mortar fitness giants are responding to the Ozempic era.
Sima Sistani is out as CEO of WeightWatchers after leading the weight loss company for two years. Tara Comonte will serve as interim CEO.
Jenny Craig, the famed weight loss and nutrition company, filed for Chapter 7 bankruptcy in May after four decades in business.
Novo Nordisk has filed lawsuits against wellness clinics and spas for selling non-FDA-approved versions of its weight-loss drugs.
While body positivity was popular in recent years, the pendulum seems to have swung the other way with the rise of weight-loss medications.
According to Barclays, the weight-loss drug industry could even climb as high as $200 billion within the next decade.
Carl Daikeler, co-founder and CEO of BODi, formerly Beachbody, explains why the company is changing its entire approach to fitness.
WeightWatchers has acquired Sequence, a telehealth provider that gives users access to diabetes and weight loss drugs.
Sign Up to Our Newsletter
